Milton C. Ault III - 17 Sep 2025 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Signature
/s/ Milton C. Ault, III
Issuer symbol
ALZN
Transactions as of
17 Sep 2025
Net transactions value
-$56,696
Form type
4
Filing time
19 Sep 2025, 16:50:09 UTC
Previous filing
17 Sep 2025
Next filing
23 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
AULT MILTON C III Director, 10%+ Owner 11411 SOUTHERN HIGHLANDS PARKWAY, SUITE 190, LAS VEGAS /s/ Milton C. Ault, III 19 Sep 2025 0001212502

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Conversion of derivative security $232,000 +100,000 +1211% $2.32 108,260 17 Sep 2025 By Ault Lending, LLC F1, F2
transaction ALZN Common Stock Sale $5,204 -2,121 -2% $2.45 106,139 17 Sep 2025 By Ault Lending, LLC F2
transaction ALZN Common Stock Sale $51,493 -20,870 -20% $2.47 85,269 18 Sep 2025 By Ault Lending, LLC F2
holding ALZN Common Stock 1,843 17 Sep 2025 Direct
holding ALZN Common Stock 11,068 17 Sep 2025 By Ault Life Sciences, Inc. F3
holding ALZN Common Stock 61 17 Sep 2025 By Ault Life Sciences Fund, LLC F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALZN Series B Convertible Preferred Stock Conversion of derivative security $232,000 -232 -15% $1000.00 1,303 17 Sep 2025 Common Stock 100,000 $2.32 By Ault Lending, LLC F2, F5, F6
holding ALZN Common Stock Purchase Warrants 13,556 17 Sep 2025 Common Stock 13,556 $108.00 By Ault Lending, LLC F2
holding ALZN Common Stock Purchase Warrants 8,667 17 Sep 2025 Common Stock 8,667 $108.00 By Ault Lending, LLC F2
holding ALZN Common Stock Purchase Warrants 1,111 17 Sep 2025 Common Stock 1,111 $108.00 By Ault Lending, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon conversion of Series B convertible preferred stock ("Series B Preferred").
F2 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.
F5 The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock.
F6 The shares of Series B Preferred have no expiration date.